The role of community pharmacists in delivering interventions for osteoporosis: A systematic review

Footnotes

CRediT roles

Sunny M. MANON: Conceptualization, methodology, investigation, data curation, writing – original draft Jonathan M. PHUONG: Conceptualization, data curation, writing – review & editing Rebekah J. MOLES: Conceptualization, writing – review & editing, supervision Ayano KELLY: Writing – review & editing Jacqueline R. CENTER: Writing – review & editing Kate LUCKIE: Writing – review & editing Chris WHITE: Writing – review & editing Stephen R. CARTER: Conceptualization, formal analysis, writing – conceptualization, review & editing, supervision.

Funding: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Disclosure of conflicts of interest: The authors declare no relevant conflicts of interest or financial relationship.

Previous presentations of the work: This work has been previously presented as part of coursework for PHAR4815 at The University of Sydney School of Pharmacy.

Acknowledgements: The authors wish to acknowledge the assistance of Yulia Ulyannikova (Librarian) for their assistance with the development of the preliminary search strategy.

Key Points

Background:

•Pharmacists have a potential role in helping to reduce gaps in osteoporosis management through the identification of high-risk patients.

•Community-based osteoporosis screening services are considered a cost-effective approach in preventing osteoporotic fractures.

•Participants feel satisfied partaking in community osteoporosis screening services and primary care physicians regard community osteoporosis screening services as useful

Findings:

•It has been demonstrated that community pharmacists have a role in delivering screening, education and medication management-based interventions for osteoporosis to patients

•In the studies reviewed, all had a positive impact on one or more patient-reported outcomes. However, whether this translated into down-stream clinical outcomes such as reduced fracture incidence remains undetermined

•Participants involved in community pharmacist interventions for osteoporosis overall reported a positive experience

留言 (0)

沒有登入
gif